Laird Norton Wetherby Wealth Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,678
Closed -$308K 943
2021
Q2
$308K Sell
1,678
-2,152
-56% -$395K 0.02% 699
2021
Q1
$585K Buy
3,830
+16
+0.4% +$2.44K 0.04% 397
2020
Q4
$596K Buy
3,814
+2
+0.1% +$313 0.04% 409
2020
Q3
$436K Sell
3,812
-41
-1% -$4.69K 0.04% 414
2020
Q2
$433K Buy
3,853
+268
+7% +$30.1K 0.04% 396
2020
Q1
$322K Buy
3,585
+241
+7% +$21.6K 0.04% 431
2019
Q4
$362K Sell
3,344
-456
-12% -$49.4K 0.04% 486
2019
Q3
$372K Sell
3,800
-307
-7% -$30.1K 0.04% 482
2019
Q2
$538K Buy
4,107
+393
+11% +$51.5K 0.06% 370
2019
Q1
$502K Sell
3,714
-4,084
-52% -$552K 0.06% 362
2018
Q4
$759K Sell
7,798
-503
-6% -$49K 0.11% 212
2018
Q3
$1.15M Sell
8,301
-1,857
-18% -$258K 0.14% 156
2018
Q2
$1.26M Buy
10,158
+326
+3% +$40.5K 0.17% 134
2018
Q1
$1.1M Sell
9,832
-763
-7% -$85.1K 0.15% 157
2017
Q4
$1.27M Sell
10,595
-796
-7% -$95.2K 0.18% 129
2017
Q3
$1.6M Buy
11,391
+590
+5% +$82.8K 0.24% 89
2017
Q2
$1.31M Sell
10,801
-597
-5% -$72.6K 0.22% 95
2017
Q1
$1.38M Sell
11,398
-215
-2% -$26.1K 0.25% 82
2016
Q4
$1.42M Buy
11,613
+1,048
+10% +$128K 0.28% 74
2016
Q3
$1.3M Buy
10,565
+497
+5% +$60.9K 0.26% 80
2016
Q2
$1.18M Buy
10,068
+208
+2% +$24.3K 0.26% 85
2016
Q1
$1.37M Sell
9,860
-351
-3% -$48.9K 0.32% 62
2015
Q4
$1.95M Buy
10,211
+49
+0.5% +$9.35K 0.47% 46
2015
Q3
$1.59M Buy
10,162
+206
+2% +$32.2K 0.41% 55
2015
Q2
$1.8M Buy
9,956
+277
+3% +$50.1K 0.43% 46
2015
Q1
$1.68M Sell
9,679
-53
-0.5% -$9.18K 0.41% 49
2014
Q4
$1.8M Buy
9,732
+210
+2% +$38.9K 0.45% 44
2014
Q3
$1.58M Buy
9,522
+152
+2% +$25.2K 0.44% 45
2014
Q2
$1.46M Buy
9,370
+179
+2% +$28K 0.41% 49
2014
Q1
$1.4M Sell
9,191
-7,911
-46% -$1.2M 0.4% 51
2013
Q4
$2.27M Sell
17,102
-24,444
-59% -$3.25M 0.65% 28
2013
Q3
$4.83M Buy
+41,546
New +$4.83M 1.51% 8